Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema

Cardiovascular Research

Volumn 80, Issue 3, 2008, Pages 339-345

  Jin, DongHao ^a   Harada, Kazuhiko ^a   Ohnishi, Shunsuke ^a   Yamahara, Kenich ^a   Kangawa, Kenji ^a   Nagaya, Noritoshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adrenomedullin; Lymphangiogenesis; Lymphoedema

Indexed keywords

ADRENOMEDULLIN; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHEDEMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADRENOMEDULLIN; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; DISEASE MODELS, ANIMAL; ENDOTHELIUM, LYMPHATIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LYMPHANGIOGENESIS; LYMPHEDEMA; MALE; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; VASODILATION;

EID: 56549093824     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn228     Document Type: Article

References (43)

1. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-478.
2. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005;438:946-953.
3. Szuba A, Rockson SG. Lymphedema: anatomy, physiology and pathogenesis. Vasc Med 1997;2:321-326.
4. Mortimer PS. Therapy approaches for lymphedema. Angiology 1997;48:87-91.
5. Kligman L, Wong RK, Johnston M, Laetsch NS. The treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Support Care Cancer 2004;12:421-431.
6. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997;188:96-109.
7. Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H et al. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 2006;114:1177-1184.
8. Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 2002;16:1985-1987.
9. Makinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 2001;20:4762-4773.
10. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T et al. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 1993;196:245-251.
11. Jougasaki M, Wei CM, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC Jr. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol 1995;268:F657-F663.
12. Kato J, Kitamura K, Eto T. Plasma adrenomedullin level and development of hypertension. J Hum Hypertens 2006;20:566-570.
13. Nakamura R, Kato J, Kitamura K, Onitsuka H, Imamura T, Cao Y et al. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats. Circulation 2004;110:426-431.
14. Okumura H, Nagaya N, Itoh T, Okano I, Hino J, Mori K et al. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 2004;109:242-248.
15. Kato J, Tsuruda T, Kita T, Kitamura K, Eto T. Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005;25:2480-2487.
16. Miyashita K, Itoh H, Sawada N, Fukunaga Y, Sone M, Yamahara K et al. Adrenomedullin provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo. FEBS Lett 2003;544:86-92.
17. Kim W, Moon SO, Sung MJ, Kim SH, Lee S, So JN et al. Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J 2003;17:1937-1939.
18. Oehler MK, Fischer DC, Orlowska-Volk M, Herrle F, Kieback DG, Rees MC et al. Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. Br J Cancer 2003;89:1927-1933.
19. Fritz-Six KL, Dunworth WP, Li M, Caron KM. Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 2008;118:40-50.
20. Rodriguez-Niedenfuhr M, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Tomarev SI et al. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol (Berl) 2001;204:399-406.
21. Nikitenko LL, Blucher N, Fox SB, Bicknell R, Smith DM, Rees MC. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms. J Cell Sci 2006;119:910-922.
22. Nishikimi T, Horio T, Yoshihara F, Nagaya N, Matsuo H, Kangawa K. Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes. Eur J Pharmacol 1998;353:337-344.
23. Boardman KC, Swartz MA. Interstitial flow as a guide for lymphangiogenesis. Circ Res 2003;92:801-808.
24. Nagaya N, Satoh T, Nishikimi T, Uematsu M, Furuichi S, Sakamaki F et al. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 2000;101:498- 503.
25. Nagaya N, Nishikimi T, Horio T, Yoshihara F, Kanazawa A, Matsuo H et al. Cardiovascular and renal effects of adrenomedullin in rats with heart failure. Am J Physiol 1999;276:R213-R218.
26. Nagaya N, Kyotani S, Uematsu M, Ueno K, Oya H, Nakanishi N et al. Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension. Circulation 2004;109:351-356.
27. Kato J, Kitamura K, Kangawa K, Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur J Pharmacol 1995;289:383- 385.
28. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995;270:4412-4417.
29. Yu Y, Sato JD. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J Cell Physiol 1999;178:235-246.
30. Ilan N, Mahooti S, Madri JA. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J Cell Sci 1998;111:3621-3631.
31. Nagaya N, Mori H, Murakami S, Kangawa K, Kitamura S. Adrenomedullin: angiogenesis and gene therapy. Am J Physiol Regul Integr Comp Physiol 2005;288:R1432-R1437.
32. Iimuro S, Shindo T, Moriyama N, Amaki T, Niu P, Takeda N et al. Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ Res 2004;95:415-423.
33. Tokunaga N, Nagaya N, Shirai M, Tanaka E, Ishibashi-Ueda H, Harada-Shiba M et al. Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia: benefits of a novel nonviral vector, gelatin. Circulation 2004;109:526-531.
34. Rutkowski JM, Boardman KC, Swartz MA. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol 2006;291:H1402-H1410.
35. Meininger CJ, Granger HJ. Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am J Physiol 1990;258:H198-H206.
36. Fang Y, Olah ME. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J Pharmacol Exp Ther 2007;322:1189-1200.
37. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993;194:720-725.
38. Okazaki T, Ogawa Y, Tamura N, Mori K, Isse N, Aoki T et al. Genomic organization, expression, and chromosomal mapping of the mouse adrenomedullin gene. Genomics 1996;37:395-399.
39. Ashton D, Hieble P, Gout B, Aiyar N. Vasodilatory effect of adrenomedullin in mouse aorta. Pharmacology 2000;61:101-105.
40. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000;5:40-46.
41. Hirakawa S, Detmar M. New insights into the biology and pathology of the cutaneous lymphatic system. J Dermatol Sci 2004;35:1-8.
42. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276:1423-1425.
43. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced giogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 2004;94:664- 670.